Source: Histopathology. Unidade: FM
Subjects: CITOCININAS (IMUNOLOGIA;MORFOLOGIA), CÉLULAS DENDRÍTICAS, INTERLEUCINAS, NEOPLASIAS PULMONARES, ESTADIAMENTO DE NEOPLASIAS, PROGNÓSTICO, FATORES DE RISCO
ABNT
SOUZA, Paola da Costa et al. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma. Histopathology, v. 61, n. 4, p. 587-596, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2559.2012.04318.x. Acesso em: 22 ago. 2024.APA
Souza, P. da C., Parra, E. R., Atanazio, M. J., Silva, O. B. da, Noleto, G. S., Ab’Saber, A. M., et al. (2012). Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma. Histopathology, 61( 4), 587-596. doi:10.1111/j.1365-2559.2012.04318.xNLM
Souza P da C, Parra ER, Atanazio MJ, Silva OB da, Noleto GS, Ab’Saber AM, Fernezlian S de M, Takagaki T, Capelozzi VL. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma [Internet]. Histopathology. 2012 ; 61( 4): 587-596.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/j.1365-2559.2012.04318.xVancouver
Souza P da C, Parra ER, Atanazio MJ, Silva OB da, Noleto GS, Ab’Saber AM, Fernezlian S de M, Takagaki T, Capelozzi VL. Different morphology, stage and treatment affect immune cell infiltration and long-term outcome in patients with non-small-cell lung carcinoma [Internet]. Histopathology. 2012 ; 61( 4): 587-596.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1111/j.1365-2559.2012.04318.x